Augmentation therapy consists of weekly intravenous (IV) infusions of Alpha-1 Antitrypsin derived from human plasma. It is used to increase the concentration of the protein in blood and lungs. Augmentation therapy is the only TGA-approved treatment for Alpha-1 Antitrypsin Deficiency. Your respiratory specialist can determine if you are an appropriate candidate for such therapy.
Read more…
Treatments
Augmentation Therapy
Drug and Other Therapies
This is among the most important types of medical therapy for the newly diagnosed individual with Alpha-1 Antitrypsin Deficiency. Although these are most relevant to lung-affected individuals, all Alphas have risks to their lungs. Some of the therapies listed are relevant for all Alpha-1 patients.
For information on Alpha-1 testing, please see page 5 of the AAA booklet.
Read more…
Surgical Options
Organ Transplantation of the lung or liver
Read more…